Suppr超能文献

结肠癌荧光淋巴结成像的可行性:FLICC。

Feasibility of fluorescence lymph node imaging in colon cancer: FLICC.

机构信息

Department of Surgery and Interventional Sciences, University College London Hospitals, NHS Foundation Trusts, GENIE Centre, University College London, Charles Bell House, 43 Foley Street, London, W1W 7TS, UK.

Department of Surgery and Interventional Sciences, University College London Hospitals, NHS Foundation Trusts, London, UK.

出版信息

Tech Coloproctol. 2018 Apr;22(4):271-277. doi: 10.1007/s10151-018-1773-6. Epub 2018 Mar 17.

Abstract

BACKGROUND

In colon cancer, appropriate tumour excision and associated lymphadenectomy directly impact recurrence and survival outcomes. Currently, there is no standard for mesenteric lymphadenectomy, with a lymph node yield of 12 acting as a surrogate quality marker. Our goal was to determine the safety and feasibility of indocyanine green (ICG) fluorescence imaging to demonstrate lymphatic drainage in colon cancer in a dose-escalation study.

METHODS

A prospective pilot study of colon cancer patients undergoing curative laparoscopic resection was performed. At surgery, peritumoural subserosal ICG injection was done to demonstrate lymphatic drainage of the tumour. A specialized fluorescence system excited the ICG and assessed lymphatics in real time. The primary outcome was the feasibility of ICG fluorescent lymphangiography for lymphatic drainage in colon cancer. Secondary outcomes were the optimal protocol for dose, injection site, and ICG lymphatic mapping timing.

RESULTS

Ten consecutive patients were evaluated (six males, mean age 69.5 years). In all, lymphatic channels were seen around the tumour to a varying extent. Eight (80%) had drainage to the sentinel node. In all cases where the lymphatic map was seen, there was no further spread 10 min after injection. In 2 patients (20%), additional lymph nodes located outside of the proposed resection margins were demonstrated. In both cases the resection was extended to include the nodes and in both patients these nodes were positive on histopathology. Factors contributing to reduced lymphatic visualization were inadequate ICG concentrations, excess India ink blocking drainage, and inflammation from tattoo placement.

CONCLUSIONS

ICG can be safely injected into the peritumoural subserosal and demonstrate lymphatic drainage in colon cancer. This proof of concept and proposed standards for the procedure can lead to future studies to optimize the application of image-guided precision surgery in colon cancer. Furthermore, this technique may be of value in indicating the need for more extended lymphadenectomy.

摘要

背景

在结肠癌中,适当的肿瘤切除和相关的淋巴结清扫术直接影响复发和生存结果。目前,肠系膜淋巴结清扫术没有标准,以 12 个淋巴结的收获作为替代质量标志物。我们的目标是确定吲哚菁绿(ICG)荧光成像在结肠癌中的安全性和可行性,以证明其在剂量递增研究中对淋巴管的示踪。

方法

对接受腹腔镜根治性切除术的结肠癌患者进行前瞻性试点研究。在手术中,在肿瘤周围的浆膜下注射 ICG 以显示肿瘤的淋巴引流。专用荧光系统激发 ICG 并实时评估淋巴管。主要结果是 ICG 荧光淋巴管造影术在结肠癌中用于淋巴引流的可行性。次要结果是剂量、注射部位和 ICG 淋巴定位时间的最佳方案。

结果

评估了 10 例连续患者(6 例男性,平均年龄 69.5 岁)。在所有患者中,肿瘤周围都可见到不同程度的淋巴通道。有 8 例(80%)有向前哨淋巴结的引流。在所有可见淋巴图的病例中,注射后 10 分钟内没有进一步扩散。在 2 例患者(20%)中,还显示了位于提议切除范围之外的额外淋巴结。在这两种情况下,都扩大了切除范围以包括这些淋巴结,并且在这两种情况下,这些淋巴结在组织病理学上均为阳性。导致淋巴可视化减少的因素包括 ICG 浓度不足、印度墨水过量阻断引流以及纹身位置的炎症。

结论

ICG 可安全地注入肿瘤周围的浆膜下,并显示结肠癌中的淋巴引流。该概念验证和建议的程序标准可用于未来的研究,以优化结肠癌图像引导精准手术的应用。此外,该技术可能有助于指示需要更广泛的淋巴结清扫术。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验